|
|
|
|
| LEADER |
00000nab a2200000uu 4500 |
| 001 |
vtls011139526 |
| 003 |
SK-MaSNL |
| 005 |
20260303125653.0 |
| 008 |
230218|2010 xo |||||||||||||||||eng| |
| 015 |
|
|
|a SNBRB
|
| 035 |
|
|
|a (urnnbn)urn:nbn:sk:snk:ar-007wx1
|
| 035 |
|
|
|a (uuid)0998bfcd-2020-4808-8efb-fa062cf86f60
|
| 035 |
|
|
|a urn:nbn:sk:snk-abaro7
|
| 040 |
|
|
|a SNKBUCL
|b slo
|c SNKBUCL
|e AACR2
|
| 041 |
0 |
|
|a eng
|
| 044 |
|
|
|a xo
|c SK
|
| 100 |
1 |
|
|a Kořístková, B.
|4 aut
|9 1144487
|
| 245 |
1 |
0 |
|a Long-term trends in the utilization of beta-blocking agents in the Czech Republic
|c B. Kořístková, D. Šalounová, M. Grundmann
|
| 700 |
1 |
|
|a Šalounová, D.
|4 aut
|9 1144488
|
| 700 |
1 |
|
|a Grundmann, M.
|4 aut
|9 1142530
|
| 773 |
0 |
|
|t Česká a slovenská farmacie : časopis České farmaceutické společnosti a Slovenské farmaceutické společnosti
|g Roč. 59, č. 1 (2010), s. 23-30
|
| 958 |
|
|
|a OND
|
| 958 |
|
|
|a EUIPO
|
| 958 |
|
|
|a article14
|
| 999 |
|
|
|c 1935700
|d 1937630
|
